Tellgen (SZSE:300642) Net Income From Continuing Operations : ¥33.5 Mil (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Tellgen Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Tellgen's net income from continuing operations for the three months ended in Mar. 2025 was ¥-0.9 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was ¥33.5 Mil.

Tellgen Net Income From Continuing Operations Historical Data

The historical data trend for Tellgen's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tellgen Net Income From Continuing Operations Chart

Tellgen Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income From Continuing Operations

Get a 7-Day Free Trial

120.55

161.06

123.75

84.70

28.38

Tellgen Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income From Continuing Operations	Get a 7-Day Free Trial															-6.04	9.60	16.20	8.61	-0.92

Tellgen Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥33.5 Mil.

Tellgen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tellgen Corp (SZSE:300642) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 412 Huiqing Road, Pudong New District, Shanghai, CHN, 201201

Website

http://www.tellgen.com

Tellgen Corp manufactures and distributes in vitro diagnostic devices for detection of tumor. Its products include tumor marker, human papillomavirus, real time PCR, DNA methylation, autoimmune antibody, infectious disease and others. The company has developed products in the fields of tumor detection, cervical cancer screening, DNA methylation detection, male infertility and prenatal and postnatal care. Its products include tumor marker series products, human papillomavirus series products, Y chromosome microdeletion detection products, real time PCR, autoimmune antibody, and others.

Executives

Zhou Ai Guo	Directors, executives
Chen Si Han	Securities Affairs Representative

Tellgen Headlines

No Headlines